Elon Musk suggests appetite-inhibiting drug Semaglutide could address rising US obesity.

Tech entrepreneur Elon Musk suggests new appetite-inhibiting drugs like Semaglutide (marketed as Ozempic and Wegovy by Novo Nordisk) could help combat rising obesity levels in the US. The drug, initially for type 2 diabetes, is found to aid weight loss by mimicking GLP-1 hormone, reducing hunger, and making people feel fuller. According to Musk, these drugs could significantly reduce obesity rates.

August 24, 2024
17 Articles